Increasing access to HIV counseling and testing through mobile services in Kenya: strategies, utilization, and cost-effectiveness.
BACKGROUND
This study compares client volume, demographics, testing results, and costs of 3 "mobile" HIV counseling and testing (HCT) approaches with existing "stand-alone" HCT in Kenya. A retrospective cohort of 62,173 individuals receiving HCT between May 2005 and April 2006 was analyzed. Mobile HCT approaches assessed were community-site mobile HCT, semimobile container HCT, and fully mobile truck HCT. Data were obtained from project monitoring data, project accounts, and personnel interviews.


RESULTS
Mobile HCT reported a higher proportion of clients with no prior HIV test than stand-alone (88% vs. 58%). Stand-alone HCT reported a higher proportion of couples than mobile HCT (18% vs. 2%) and a higher proportion of discordant couples (12% vs. 4%). The incremental cost-effectiveness of adding mobile HCT to stand-alone services was $14.91 per client tested (vs. $26.75 for stand-alone HCT); $16.58 per previously untested client (vs. $43.69 for stand-alone HCT); and $157.21 per HIV-positive individual identified (vs. $189.14 for stand-alone HCT).


CONCLUSIONS
Adding mobile HCT to existing stand-alone HCT seems to be a cost-effective approach for expanding HCT coverage for reaching different target populations, including women and young people, and for identifying persons with newly diagnosed HIV infection for referral to treatment and care.
Grabbe
Kristina L
KL
US Centers for Disease Control and Prevention, Global AIDS Program, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA 30333, USA. kgrabbe@cdc.gov
Menzies
Nick
N
Taegtmeyer
Miriam
M
Emukule
Gideon
G
Angala
Patrick
P
Mwega
Irene
I
Musango
Geraldine
G
Marum
Elizabeth
E
D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D003362:Cost-Benefit Analysis; D003376:Counseling / Q000191:economics / Q000379:methods; D004196:Disease Outbreaks; D005260:Female; D015658:HIV Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy; D017048:Health Care Costs; D006297:Health Services Accessibility / Q000191:economics*; D006801:Humans; D007630:Kenya / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D008952:Mobile Health Units / Q000191:economics / Q000706:statistics & numerical data*; D011635:Public Health Administration / Q000191:economics / Q000379:methods; D012017:Referral and Consultation; D012189:Retrospective Studies; D055815:Young Adult
JAMA. 2006 Aug 16;296(7):859-62
16905791
AIDS. 2009 Jan 28;23(3):395-401
19114865
J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):218-24
16394855
J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):422-31
18931624
BMJ. 1992 Jun 20;304(6842):1605-9
1628088
Am J Public Health. 2006 Jan;96(1):114-9
16317205
Soc Sci Med. 2009 Feb;68(4):749-57
19101063
JAMA. 1992 Dec 16;268(23):3338-43
1453526
JAMA. 1996 Oct 16;276(15):1253-8
8849754
Health Policy Plan. 2002 Jun;17(2):187-95
12000779
Trop Med Int Health. 2007 Nov;12(11):1315-22
17949401
AIDS Behav. 2010 Feb;14(1):1-10
18843530
AIDS. 2003 Mar 28;17(5):733-40
12646797
Lancet. 2008 Aug 23;372(9639):669-84
18687459
AIDS. 2008 Mar 12;22(5):617-24
18317003
Am J Public Health. 1999 Sep;89(9):1397-405
10474559
AIDS. 1991 Jan;5(1):61-7
2059362
AIDS Behav. 2008 May;12(3):363-73
18161018
Lancet. 2000 Jul 8;356(9224):113-21
10963247
AIDS. 2008 Oct 1;22(15):2019-24
18784464